People: NeuroMetrix, Inc. (NURO.O)

NURO.O on Consolidated Issue listed on NASDAQ Global Market

2.24USD
9 Feb 2010
Price Change (% chg)

$0.05 (+2.37%)
Prev Close
$2.24
Open
--
Day's High
$2.30
Day's Low
$2.10
Volume
23,783
Avg. Vol
15,378
52-wk High
$3.60
52-wk Low
$1.11

view people for:

Summary

Name Age Since Current Position
Gozani, Shai 45 2008 Chairman of the Board, Chief Executive Officer, President, Secretary
Higgins, Thomas 58 2009 Chief Financial Officer, Senior Vice President
Christensen, Walter 2009 Senior Vice President - Global Sales
Daniello, Guy 64 2003 Senior Vice President - Information Technology
Williams, Michael 52 2003 Senior Vice President - Engineering
Goodman, David 53 2004 Director
Lortz, W. Mark 57 2004 Director
LaMantia, Charles 69 2004 Director
Hinkle, Allen 58 2006 Director
Surgenor, Timothy 49 2009 Director
» Insider Trading

Biographies

Name Description
Gozani, Shai Shai N. Gozani, M.D., Ph.D. founded NeuroMetrix, Inc. in 1996 and currently serves as Chairman of Board of Directors and as President and Chief Executive Officer and Secretary. Since founding the Company in 1996, Dr. Gozani has served in a number of positions at the Company including Chairman since 1996, President from 1996 to 1998 and from 2002 to the Present, Chief Executive Officer since 1997 and Secretary since July 2008. Dr. Gozani holds a B.S. in computer science, an M.S. in Biomedical Engineering and a Ph.D. in Neurobiology, from the University of California, Berkeley. He also received an M.D. from Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences at M.I.T. Prior to forming the Company, Dr. Gozani completed a neurophysiology research fellowship in the laboratory of Dr. Gerald Fischbach at Harvard Medical School. Dr. Gozani has published articles in the areas of basic and clinical neurophysiology, biomedical engineering and computational chemistry.
Higgins, Thomas Mr. Thomas T. Higgins is Chief Financial Officer, Senior Vice President of NeuroMetrix, Inc. Mr. Higgins brings to NeuroMetrix a broad set of financial management and operations skills gained in over 30 years of experience with publicly traded companies in life sciences, specialty chemicals and financial services. He has extensive international experience with a particular emphasis on Japan, Southeast Asia and the Middle East. Prior to joining NeuroMetrix, Mr. Higgins was Executive Vice President and Chief Financial Officer at Caliper Life Sciences. Inc, a provider of technology and services for life sciences research, during the period starting in 2005 which saw strong revenue growth, product line expansion via acquisitions, and substantial improvement in its financial results. Before Caliper, Mr. Higgins was Executive Vice President, Operations and Chief Financial Officer at V.I. Technologies, Inc. ("Vitex"), a biotechnology company addressing blood safety. Mr. Higgins directed the financial side of the business, including fund raising, and was also responsible for Vitex' FDA-regulated plasma manufacturing business until its divestiture in 2001. Prior to joining Vitex in 1998, Mr. Higgins served at Cabot Corporation from 1985 in various senior finance and operations roles. His last position at Cabot was President of Distrigas of Massachusetts Corporation, a subsidiary involved in the liquefied natural gas business, and prior to that he was responsible for Cabot's Asia Pacific carbon black operations. Before joining Cabot, Mr. Higgins was with PricewaterhouseCoopers where he started his career. Mr. Higgins holds a Bachelor of Business Administration with honors from Boston University.
Christensen, Walter Mr. Walter Christensen is Senior Vice President - Global Sales of NeuroMetrix, Inc. Mr. Christensen brings over 30 years of experience in global, national and regional sales leadership for small and large multi-national medical device companies. In addition, Mr. Christensen has been involved in creating, expanding and reorganizing multi-national field sales network operations including direct and indirect sales staff. Prior to joining NeuroMetrix, Mr. Christensen was the Senior Vice President of Global Sales at Stereotaxis, Inc. At Stereotaxis he created sales and business network strategies that established market share in Asia, Europe and the United States. Prior to Stereotaxis Mr. Christensen was Vice President, mid America zone at Philips Medical Systems. At Philips Medical Systems he created and expanded a successful U.S. sales operation that integrated the use of field sales personnel and a large dealer organization. Previously, Mr. Christensen served as General Manager at General Electric Medical Systems where he was responsible for the Nuclear/PET Division in North and South America. Mr. Christensen received his degree in business administration from Harrisburg Community College, Harrisburg, PA and his Radiology Technology Certification from Holy Spirit Hospital, Camp Hill, PA.
Daniello, Guy Mr. Guy Daniello has served as Senior Vice President of Information Technology of NeuroMetrix, Inc. since July 2003, and, prior to that time, as Vice President of Information Technology and Director of Information Technology since 1998. Prior to joining NeuroMetrix, Mr. Daniello was an independent software consultant, the Senior Vice President of Engineering at Shiva Corporation from 1996 to 1997, and the Chief Technology Officer & Vice President of Product Development at Gandalf Technologies from 1993 to 1996. In 1991 he founded Network Architects, a software company. Prior to starting Network Architects, he served as President and Chief Executive Officer of Datamedia Corp. and the Director of Small Systems Development at Honeywell Information Systems. Mr. Daniello holds a B.S. in business administration from Northeastern University.
Williams, Michael Dr. Michael Williams, Ph.D. has served as Senior Vice President of Engineering of NeuroMetrix, Inc. since July 2003 and, prior to that time, as Vice President of Engineering since May 2000. From March 1996 to January 2000, Dr. Williams served as Division President at Radionics, where he was responsible for all software-based products, including treatment planning and image-guided surgery. Prior to Radionics, he served as an engineer at Hughes Aircraft Space & Communications Group. Dr. Williams received a B.S. in physics and mathematics from University of Puget Sound and an M.S. and Ph.D. in Physics from Brown University.
Goodman, David Dr. David E. Goodman, M.D. has served as a Member of Board of Directors of NeuroMetrix Inc. since June 2004. Since September 2008, Dr. Goodman has served as Executive Vice President of Business Development for Masimo Corporation, a manufacturer of non-invasive patient monitors. From 2006 to 2008, Dr. Goodman served as an independent consultant providing product design, regulatory and analytical consulting services to medical device and biopharmaceutical companies and also served in this capacity from 2003 to 2004 and from 2001 to 2002. From 2005 to 2006, Dr. Goodman served as President and Chief Executive Officer of BaroSense, Inc., a medical device company focused on developing minimally invasive devices for the long-term treatment of obesity. From 2004 to 2005, Dr. Goodman served as President and Chief Executive Officer of Interventional Therapeutic Solutions, Inc., an implantable drug delivery systems company. From 2002 to 2003, Dr. Goodman served as Chairman, President and Chief Executive Officer of Pherin Pharmaceuticals, a pharmaceutical discovery and development company. From 1994 to 2001, Dr. Goodman held various positions, including Chief Executive Officer, Chief Medical Officer and director, for LifeMasters Supported SelfCare, Inc., a disease management services company that Dr. Goodman founded. Dr. Goodman holds a B.A.S. in applied science and bioengineering and a M.S.E. in bioengineering from the University of Pennsylvania. He also received an M.D. from Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology
Lortz, W. Mark W. Mark Lortz has served as a Member of Board of Directors of NeuroMetrix, Inc. since June 2004. Since 2004, Mr. Lortz has served as an independent consultant providing services to medical device companies. Mr. Lortz served as President and Chief Executive Officer of TheraSense, Inc., a medical device company, from 1997, and as Chairman of TheraSense from 1998, until Abbott Laboratories' acquisition of TheraSense in April 2004. From 1991 to 1997, Mr. Lortz held various positions, including Group Vice President for Worldwide Operations and International Franchise Development, Group Vice President for Worldwide Business Operations and Vice President of Operations, for LifeScan, Inc., a division of Johnson & Johnson that specializes in medical device technology. Mr. Lortz currently serves as a director of Cutera, Inc., a medical device company that designs and develops laser and other light-based aesthetic systems. Mr. Lortz holds a B.S. in Engineering Science from Iowa State University and an M.B.A. in Management from Xavier University.
LaMantia, Charles Charles R. LaMantia has served as a Member of Board of Directors of NeuroMetrix, Inc. since November 2004. In July 1999, Mr. LaMantia retired from the position of Chief Executive Officer, Chairman, and President of Arthur D. Little, Inc, a worldwide professional service company with activities in management consulting, technology and product development, and environmental, health and safety. Mr. LaMantia served as Chief Executive Officer, and President of Arthur D. Little from July 1988 to July 1999. From October 1986 to July 1988, Mr. LaMantia held the position of President and Chief Operating Officer at Arthur D. Little. From 1981 to 1986, Mr. LaMantia served as President and Chief Executive Officer of Koch Process Systems, Inc., an integrated engineering and manufacturing company, owned by Koch Industries. From 1977 to 1981, Mr. LaMantia served as Vice President in charge of Arthur D. Little's Chemical and Metallurgical Engineering business. Mr. LaMantia currently serves on the Board of Directors of State Street Corporation. He is a member of the Advisory Board of the Carroll School of Management at Boston College. Mr. LaMantia received a B.A. B.S., M.S., and Sc.D. in chemical engineering from Columbia University and completed the Advanced Management Program of Harvard Business School. He was a Sloan Foundation Fellow, a National Science Foundation Fellow, and is a member of Phi Beta Kappa and Tau Beta Pi. He served as an officer in the United States Navy.
Hinkle, Allen Dr. Allen J. Hinkle, M.D. has served as a Member of Board of Directors of NeuroMetrix, Inc. since January 2006. Dr. Hinkle has served as the Chief Medical Officer and Senior Vice President for Tufts Health Plan in Massachusetts, a health insurance provider, where he is responsible for medical management programs and initiatives, since September 2004. Prior to becoming the Chief Medical Officer, Dr. Hinkle was Senior Medical Director and Vice President of Health Care Quality, Policy and Innovations at Blue Cross Blue Shield of Massachusetts, a health insurance provider, from 2001 through September 2004. From 1995 to 2001, Dr. Hinkle was the Chief Medical Officer and Senior Vice President of Quality—Healthcare Management for Anthem Blue Cross Blue Shield of New Hampshire and Matthew Thornton Plan, health insurance provider organizations. Dr. Hinkle has over 30 years of experience in the healthcare field. Dr. Hinkle received a B.S. from the University of Massachusetts at Amherst and an M.D. from Albert Einstein College of Medicine in New York. He is board certified in pediatrics and anesthesiology and is an Associate Professor of Anesthesiology and Pediatrics at Dartmouth Medical School and Associate Professor of Medicine at Tufts University School of Medicine. He also owns several U.S. patents on medical devices.
Surgenor, Timothy Mr. Timothy R. Surgenor has served as a Member of Board of Directors of NeuroMetrix, Inc. since April 2009. Since April 2009, Mr. Surgenor has been a partner at Red Sky Partners, LLC., a provider of growth and project financing strategies for life-science companies. From 2003 to 2009, Mr. Surgenor served as President, Chief Executive Officer and director of Cyberkinetics Neurotechnology Systems, a medical device company. From January 1999 to January 2003, Mr. Surgenor was Executive Vice President at Haemonetics Corporation, which is a medical device company. From 1994 to 1999, Mr. Surgenor was President of Genzyme Tissue Repair, the cell therapy division of Genzyme Corporation. Previously, Mr. Surgenor was Executive Vice President and Chief Financial Officer of BioSurface Technology, Inc. and also held various positions in operations at Integrated Genetics. Mr. Surgenor received a B.A. in Biochemistry from Williams College and an M.B.A. from Harvard Business School.

Basic Compensation

Name Fiscal Year Total
Gozani, Shai 819,590
Higgins, Thomas --
Christensen, Walter --
Daniello, Guy 447,277
Williams, Michael 433,201
Goodman, David --
Lortz, W. Mark --
LaMantia, Charles 3
Hinkle, Allen --
Surgenor, Timothy --
As Of 30 Dec 2008

Options Compensation

Name Options Value
Gozani, Shai 375,000 1,406,250
Higgins, Thomas 0 0
Christensen, Walter 0 0
Daniello, Guy 50,515 932,202
Williams, Michael 42,299 1,201,350
Goodman, David 0 0
Lortz, W. Mark 0 0
LaMantia, Charles 0 0
Hinkle, Allen 0 0
Surgenor, Timothy 0 0

Insider Trading

Name Shares Traded Price
FLYNN JAMES E 922,620 $2.00
FLYNN JAMES E 1,626,053 $2.00
GOZANI SHAI N 100,000 $1.30
GOZANI SHAI N 61,373 $1.70
INTEGRAL CAPITAL PARTNERS VII L P 446,716 $1.80
INTEGRAL CAPITAL MANAGEMENT VII L L C 446,716 $1.80
INTEGRAL CAPITAL MANAGEMENT VIII L L C 233,576 $1.80
INTEGRAL CAPITAL PARTNERS VIII L P 233,576 $1.80
INTEGRAL CAPITAL MANAGEMENT VII L L C 12,745 $1.67
INTEGRAL CAPITAL PARTNERS VIII L P 6,663 $1.67
INTEGRAL CAPITAL PARTNERS VII L P 12,745 $1.67
INTEGRAL CAPITAL MANAGEMENT VIII L L C 6,663 $1.67
INTEGRAL CAPITAL MANAGEMENT VIII L L C 14,386 $1.65
INTEGRAL CAPITAL MANAGEMENT VII L L C 27,514 $1.65
INTEGRAL CAPITAL PARTNERS VIII L P 14,386 $1.65
INTEGRAL CAPITAL PARTNERS VII L P 27,514 $1.65
INTEGRAL CAPITAL PARTNERS VIII L P 3,800 $4.17
INTEGRAL CAPITAL MANAGEMENT VII L L C 7,300 $4.17
INTEGRAL CAPITAL PARTNERS VII L P 7,300 $4.17
INTEGRAL CAPITAL MANAGEMENT VIII L L C 3,800 $4.17
INTEGRAL CAPITAL PARTNERS VIII L P 5,900 $4.48
INTEGRAL CAPITAL MANAGEMENT VII L L C 10,000 $4.48
INTEGRAL CAPITAL PARTNERS VII L P 10,000 $4.48
INTEGRAL CAPITAL MANAGEMENT VIII L L C 5,900 $4.48
INTEGRAL CAPITAL PARTNERS VII L P 4,690 $6.59
» Full list on Insider Trading
view people for: